Filing Details
- Accession Number:
- 0001707925-25-000075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-27 16:31:40
- Reporting Period:
- 2025-05-22
- Filing Date:
- 2025-05-27
- Accepted Time:
- 2025-05-27 16:31:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1707925 | Linde Plc | LIN | Industrial Inorganic Chemicals (2810) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1850358 | Sean Durbin | C/O Linde Plc Forge, 43 Church Street West Woking Surrey X0 GU216HT | Executive Vp, North America | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2025-05-22 | 4,637 | $456.19 | 8,151 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2025-05-22 | 7,795 | $176.63 | 15,946 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2025-05-22 | 5,171 | $456.82 | 10,775 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2025-05-22 | 2,624 | $456.82 | 8,151 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Options (right to buy) | Disposition | 2025-05-22 | 7,795 | $0.00 | 7,795 | $176.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2029-03-20 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Options (right to buy) | $468.77 | 2035-03-07 | 10,889 | 10,889 | Direct | |
Ordinary Shares | Restricted Stock Units | $0.00 | 1,551 | 1,551 | Direct | ||
Ordinary Shares | Deferred Stock Units | $0.00 | 338 | 338 | Direct | ||
Ordinary Shares | Stock Options (right to buy) | $253.68 | 2031-03-08 | 19,070 | 19,070 | Direct | |
Ordinary Shares | Restricted Stock Units | $0.00 | 0 | 0 | Direct | ||
Ordinary Shares | Stock Options (right to buy) | $173.13 | 2030-03-09 | 7,045 | 7,045 | Direct | |
Ordinary Shares | Restricted Stock Units | $0.00 | 1,470 | 1,470 | Direct | ||
Ordinary Shares | Stock Options (right to buy) | $354.14 | 2033-03-07 | 10,540 | 10,540 | Direct | |
Ordinary Shares | Restricted Stock Units | $0.00 | 1,595 | 1,595 | Direct | ||
Ordinary Shares | Performance Share Units (ROC) | $0.00 | 0 | 0 | Direct | ||
Ordinary Shares | Stock Options (right to buy) | $0.00 | 2028-03-07 | 0 | 0 | Direct | |
Ordinary Shares | Stock Options (right to buy) | $465.29 | 2034-03-07 | 9,610 | 9,610 | Direct | |
Ordinary Shares | Stock Options (right to buy) | $270.99 | 2032-03-07 | 12,395 | 12,395 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2035-03-07 | 10,889 | 10,889 | Direct |
1,551 | 1,551 | Direct | |
338 | 338 | Direct | |
2031-03-08 | 19,070 | 19,070 | Direct |
0 | 0 | Direct | |
2030-03-09 | 7,045 | 7,045 | Direct |
1,470 | 1,470 | Direct | |
2033-03-07 | 10,540 | 10,540 | Direct |
1,595 | 1,595 | Direct | |
0 | 0 | Direct | |
2028-03-07 | 0 | 0 | Direct |
2034-03-07 | 9,610 | 9,610 | Direct |
2032-03-07 | 12,395 | 12,395 | Direct |
Footnotes
- Ordinary shares withheld to cover exercise price and tax withholdings.
- This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
- Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
- Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
- Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
- This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
- Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis
- This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
- Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
- Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
- Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
- The PSU paid out on 3/10/2025 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.